Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

After a year in which deal value fell across the healthcare sector, pharma and biotech companies are poised for an active 2021.

Companies willing to invest shrewdly in the downturn will emerge from it stronger.

Gaining an edge in a market reset: Bain's annual Global M&A report looks at how turbulent times produce strategic winners and losers.

I want to talk to your experts in: Please select an industry from the dropdown list

We work with ambitious leaders who want to define the future, not hide from it. Together, we achieve extraordinary outcomes.

Your email Please enter a valid email address